AXQ Capital LP increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 301.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,239 shares of the medical equipment provider's stock after purchasing an additional 11,440 shares during the quarter. Intuitive Surgical accounts for 0.7% of AXQ Capital LP's portfolio, making the stock its 8th largest position. AXQ Capital LP's holdings in Intuitive Surgical were worth $6,060,000 at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in ISRG. Brighton Jones LLC increased its position in shares of Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after purchasing an additional 731 shares during the last quarter. Sivia Capital Partners LLC lifted its position in shares of Intuitive Surgical by 3.8% during the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider's stock worth $504,000 after purchasing an additional 34 shares during the last quarter. Schnieders Capital Management LLC. grew its stake in Intuitive Surgical by 38.0% in the second quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider's stock worth $529,000 after purchasing an additional 268 shares in the last quarter. Osterweis Capital Management Inc. acquired a new position in Intuitive Surgical in the second quarter worth about $200,000. Finally, Main Street Financial Solutions LLC increased its holdings in Intuitive Surgical by 92.4% in the second quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider's stock valued at $1,592,000 after buying an additional 1,407 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In related news, Director Gary S. Guthart sold 10,000 shares of the company's stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total value of $4,000,000.00. Following the completion of the sale, the director owned 1,245,679 shares of the company's stock, valued at $498,271,600. This represents a 0.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 77 shares of the stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $375.57, for a total transaction of $28,918.89. Following the completion of the transaction, the executive vice president owned 881 shares of the company's stock, valued at $330,877.17. This represents a 8.04% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 11,658 shares of company stock valued at $4,649,835 in the last quarter. 0.60% of the stock is owned by insiders.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on ISRG shares. BTIG Research lowered their price target on Intuitive Surgical from $512.00 to $469.00 and set a "buy" rating for the company in a report on Friday, July 17th. BNP Paribas Exane upgraded Intuitive Surgical to an "outperform" rating in a research note on Tuesday, July 28th. The Goldman Sachs Group set a $558.00 price objective on shares of Intuitive Surgical in a report on Wednesday, May 27th. Royal Bank Of Canada lowered their target price on shares of Intuitive Surgical from $650.00 to $600.00 and set an "outperform" rating for the company in a research note on Monday, July 13th. Finally, Evercore set a $430.00 target price on shares of Intuitive Surgical in a report on Monday, July 6th. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus target price of $508.68.
View Our Latest Analysis on Intuitive Surgical
Intuitive Surgical Price Performance
Shares of NASDAQ ISRG opened at $369.83 on Friday. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The business's fifty day moving average price is $382.20 and its two-hundred day moving average price is $429.04. The firm has a market capitalization of $130.65 billion, a PE ratio of 42.36, a P/E/G ratio of 2.81 and a beta of 1.47.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The firm had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. During the same period last year, the firm posted $1.81 EPS. Intuitive Surgical's quarterly revenue was up 18.4% compared to the same quarter last year. Equities research analysts expect that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
